}

06:45 – 08:45

Lobby Entrance

- (outside)

10th Annual CFID Bug Run

}

07:00 – 13:30

North Tower

- Parksville

Escape Room

07:00 - 12:30
Sign Up (last group entrance 12:30)
}

07:00 – 14:00

North Tower

- Junior Ballroom Foyer

Conference Registration

}

07:00 – 14:00

North Tower

- Junior Ballroom Foyer

Internet Café

}

07:00 – 16:00

North Tower (lower lobby)

- Gulf Island A

Speaker Ready Room

}

07:00 – 18:00

B Tower

- Beluga

Sponsor Lounge – BD

}

07:00 – 08:45

North Tower (4th floor)

- Port McNeill

CCM AGM

07:00 - 07:30
Breakfast
07:30 - 08:45
Meeting
}

07:00 – 08:45

B Tower (3rd Floor)

- Orca

AMMI Canada Phage Working Group Steering Committee Meeting

07:00 - 07:30
Breakfast
07:30 - 08:45
Meeting
}

07:00 – 08:45

South Tower (4th floor)

- Granville

AMMI Canada Paediatric Committee and PICNIC Meeting

07:00 - 07:30
Breakfast
07:20 - 08:15
Meeting
08:15 - 08:45
Presentation by Dr. David Kimberlin
}

09:00 – 11:00

North Tower

- Grand Ballroom BC

Plenary

What’s Hot in Paediatric Infectious Disease/Medical Microbiology/Antimicrobial Stewardship/IPAC/Adult Infectious Disease

09:00 - 09:05
Welcome and Introductions

MODERATORS:
Earl Rubin (QC)
Larissa Matukas (ON)

09:05 - 09:25
What's Hot in Paediatric Infectious Disease

SPEAKER:
Kirk Leifso (ON)

At the end of this session, participants should be able to:

  • Describe recent findings that impact the practice of paediatric infectious disease
09:25 - 09:45
What's Hot in Medical Microbiology

SPEAKER:
Marthe Charles (BC)

At the end of this session, participants should be able to:

  • Describe recent findings that impact the practice of medical microbiology
09:45 - 10:05
What's Hot in Antimicrobial Stewardship

SPEAKER:
Nicole Le Saux (ON)

At the end of this session, participants should be able to:

  • Describe recent findings that impact the practice of antimicrobial stewardship
10:05 - 10:25
What's Hot in Infection Prevention and Control

SPEAKER:
Jennie Johnstone (ON)

At the end of this session, participants should be able to:

  • Describe recent findings that impact the practice of infection prevention and control
10:25 - 10:45
What's Hot in Adult Infectious Disease

SPEAKER:
Christian Lavallée (QC)

At the end of this session, participants should be able to:

  • Describe recent findings that impact the practice of adult infectious disease
10:45 - 11:00
Panel Question & Answer
}

11:00 – 14:00

North Tower

- Pavilion Ballroom and Junior Ballroom

Exhibit Hall Open / Poster Viewing

}

11:00 – 11:30

North Tower

- Pavilion Ballroom and Junior Ballroom

Break

}

11:30 – 12:30

North Tower

- Grand Ballroom A

Adult-designed Vaccines – A Paradigm Shift Long Overdue

(co-developed learning activity, pre-registration required to maximum of 150 participants)

MODERATOR:
Vanessa Meier-Stephenson (AB)

SPEAKERS:
Brian Ward (QC)
Greg Tyrrell (AB)

At the end of this session, participants should be able to:

  • Describe the paradigm shift to now having options of adult-designed vaccines
  • Summarize the available adult-designed vaccines
  • Discuss NACI’s recommendations regarding the use of adult-designed vaccines

This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and Merck Canada and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.

}

11:30 – 12:30

North Tower

- Grand Ballroom D

HPV Primary Screening Implementation in British Columbia: From the Clinical Perspective and Laboratory Perspective

(co-developed learning activity, pre-registration required to maximum of 150 participants)

MODERATOR:
Susan Poutanen (ON)

SPEAKERS:
Lily Proctor (BC)
Mel Krajden (BC)

At the end of this session, participants should be able to:

  • Describe different pragmatic approaches to taking action regarding cervical cancer prevention
  • Discuss British Columbia’s approach as a case example

This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and Roche and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.

}

12:30 – 13:30

North Tower

- Pavilion Ballroom and Junior Ballroom

Lunch in Exhibit Hall

}

12:45 – 13:45

North Tower

- Pavilion Ballroom

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Rapid Fire Session A Poster Presenters at Posters to Answer Questions

 

RFA01 (#27) Increased rates of laboratory confirmed cases of syphilis in Western Canadian vs Eastern Canadian blood donors: 2022-2023
Presenting: Steven Drews
RFA02 (#88) Sample processing methodology alters observed diversity in metagenomic and metatranscriptomic microbiome profiles from human stool
Presenting: Molly Pratt
RFA03 (#174) Optimizing methods for the genomic surveillance of viral pathogens in wastewater
Presenting: Ian Restall
RFA04 (#191) Molecular epidemiology of rotavirus strains in Quebec from January to June 2023
Presenting: Maude Paquette
RFA05 (#68) Prevalence of antibodies to human t-cell lymphotropic virus-1/2 in Canada over thirty-three years of monitoring in blood donors
Presenting: Steven Drews
RFA06 (#141) Assessing the potential for specimen pooling to streamline nosocomial surveillance of methicillin resistant Staphylococcus aureus (MRSA)
Presenting: Mohammed Alqatani
RFA07 (#182) Applying whole genome approaches to identify and resolve influenza A outbreaks in humans and animals
Presenting: Shannon Russell
RFA08 (#183) Epidemiology and clinical characteristics of severe malaria in Canada, 2014-2022
Presenting: Mireille Desroches
RFA09 (#295) Emergence of a novel FRI-type carbapenemase (blaFRI -12) in Enterobacter cloacae complex located on a novel IncR plasmid isolated in Canada
Presenting: Laura Mataseje
RFA10 (#370) Association between use of a voluntary isolation centre and transmission of SARS – CoV -2: a matched cohort study of households
Presenting: Kevin Brown
RFA11 (#309) A Comprehensive Risk Assessment Algorithm -guided SARS CoV -2 Vaccine Composition Strategy
Presenting: Victor Kramer
RFA12 (#312) FluViewer: an automated bioinformatic pipeline for generating influenza A virus consensus genomes regardless of viral subtype or host
Presenting: Kevin Kuchinski
}

12:45 – 13:45

North Tower

- Pavilion Ballroom

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Rapid Fire Session B Poster Presenters at Posters to Answer Questions
RFB01 (#69) Use of Dalbavancin in treatment of Acute Bacterial Skin and Skin Structure Infections: Prospective Case Series from a Canadian Perspective
Presenting: Wayne Leung
RFB02 (#258) Verification of the Aptima Bacterial Vaginosis (BV) and
Candida/Trichomonas (CV/TV) assays on the Hologic Panther
Presenting: Emily MacAdam
RFB03 (#41) Clinical validation of an optimized and automated agnostic diagnostic
assay for detection of respiratory viruses
Presenting: Nick Gauthier
RFB04 (#58) Multivariate analysis of risk factors predicting 28 -day mortality among adult patients presenting with bacteremia in the emergency department
Presenting: Noémie Laurier
RFB05 (#75) Infectious diseases consultation is associated with reduced mortality in hospitalized patients with Gram-negative bloodstream infection: a population-wide cohort study
Presenting: Sean Ong
RFB06 (#198) HCV Reinfection Among People Who Use Drugs (PWUD) treated for HCV Infection:
A Long -Term View
Presenting: Saina Beitari
RFB07 (#213) Impact of antimicrobial copper surfaces on microbial load and healthcare-acquired infection rates in long -term care settings: a comparative study in Canada
Presenting: Hasan Hamze
RFB08 (#133) MRSA isolates resistant to trimethoprim-sulfamethoxazole by VITEK2 and BD
Phoenix antibiotic susceptibility testing systems but susceptible by Etest
and disk diffusion harbour a resistant subpopulation
Presenting: Farhan Khan
RFB09 (#270) Validation of Python scripts vs. Excel for cleaning, analysis, and visualization
of surveillance and methods evaluation data
Presenting: Yerin Lee
RFB10 (#287) Impacts of SARS -CoV -2 and non-pharmaceutical interventions on the seasonal incidence of hospitalizations for acute respiratory diseases among children
Presenting: Christina Lukac
RFB11 (#306) Clinical and public health management of bacterial gastroenteritis in the world of culture -independent diagnostic testing (CIDT): A pilot study to evaluate kinetics
of bacterial shedding by culture and CIDT
Presenting: Nathan McCartney
RFB12 (#324) SARS -CoV -2 seropositivity in Alberta: the Omicron era
Presenting: Sa’adiya Umar
}

12:45 – 13:45

North Tower

- Junior Ballroom

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Poster Presenters at Posters to Answer Questions

 

FP001 (#33) A case of severe native valve infective endocarditis (IE) caused by Streptobacillus moniliformis (Rat-bite fever)
Presenting: Chu (Sandy) Wang
FP002 (#49) Polymicrobial Streptococcus mitis and Vagococcus fluvialis Infective Endocarditis
Presenting: Alexander Pupek
FP003 (#87) Partially-treated Actinomyces orisnative mitral valve endocarditis masquerading as subacute, relapsing fevers over a 6-month period
Presenting: Jason Zou
FP004 (#106) Bacteremia secondary to a phenotypically susceptible blaCTX-M27positive Escherichia coli
Presenting: Geneviève Amaral
FP005 (#120) Presumed travel-related pulmonary cystic echinococcosis in a child: Case report
Presenting: Heba Hamed
FP006 (#129) Cutaneous Alternariosis in Acute Lymphocytic Leukemia
Presenting: Reza Rahimi Shahmirzadi
FP007 (#145) Snowshoe Hare Virus meningoencephalitis in a child
Presenting: Alison Lopez
FP008 (#158) Malaria in Canada? A case of Babesia microti infection in a returning traveller from Nova Scotia
Presenting: Jamil Kanji
FP009 (#166) Bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) treatment for multidrug-resistant extrapulmonary tuberculosis (MDR-EPTB) in Canada: a case report
Presenting: Jollee Fung
FP010 (#196) First case report of disseminated gonococcal arthritis in a Canadian province
Presenting: Nessika Karsenti
FP011 (#197) Navigating the challenges: Managing mold, mycobacterial, and viral infections in a hematopoietic stem cell transplant recipient
Presenting: Wayne Leung
FP012 (#218) Candida blankii : The difficult capture of a fungus with pathogenic potential
Presenting: Arjun Sharma
FP013 (#245) Unmasking complexity: Navigating the diagnostic challenge of a false-positive cryptococcal antigen in chronic meningitis with suspected indolent CNS B-cell lymphoproliferative neoplasm
Presenting: Melissa Fowler
FP014 (#246) Less is more? Two cases of cryptococcosis treated using single-dose liposomal amphotericin B as part of induction therapy in solid organ transplant recipients
Presenting: Carson Lo
FP015 (#252) A palatable diagnosis: Disseminated Blastomycoses with Mucocutaneous involvement
Presenting: Helen Genis
FP016 (#255) Bilateral thigh abscesses caused by Mycobacterium chelonae in the context of patient-administered testosterone injections
Presenting: Lili Ataie
FP017 (#265) Delayed presentation of rhinoscleroma with laryngeal involvement in a patient who immigrated to Canada from El Salvador 25 years prior to diagnosis
Presenting: Lise Bondy
FP018 (#266) Invasive Pulmonary Irpex lacteus infection in an immunocompromised patient with Myelodysplastic Syndrome
Presenting: Elizabeth Simms
FP019 (#277) Prosthetic joint infection with carbapenem-resistant Acinetobacter baumannii treated with colistin and sulbactam-durlobactam: A case report and review of the literature
Presenting: Roy Hutchings
FP020 (#278) A case report of long-standing Profound Neutropenia with uncertain etiology and concomitant Cutaneous Fungal Infection
Presenting: Esraa Babaeer
FP021 (#281) Leveraging additive antibiotic effects: management of an extensively drug resistant Pseudomonas aeruginosa bloodstream infection
Presenting: Andrew Purssell
FP022 (#340) Rituximab friend or foe?: PML in a non-HIV patient with non-Hodgkin lymphoma post rituximab and autologous stem cell transplant treatment
Presenting: Tanna Lauriente
FP023 (#353) Chronic schistosomiasis in a paediatric patient following allogeneic haematopoietic stem cell transplantation: A case report and review of the literature
Presenting: Stephanie Zahradnik
FP024 (#359) Two simultaneous carbapenemase-producing Enterobacterales (CPE) outbreaks in a Canadian tertiary care centre: Highlighting gaps in CPE screening and outbreak management
Presenting: Matthew Driedger
FP025 (#361) Blastomyces dermatitidis mastoiditis and venous sinus thrombosis in an adolescent: an uncommon pairing of common diseases
Presenting: Matthew Kochan
FP026 (#262) When malaria gets mixed: Complications in Plasmodium species detection with multiplexed PCR
Presenting: Kelly Lozinski
}

14:00 – 16:00

North Tower

- Grand Ballroom Foyer

Conference Registration

}

14:00 – 15:00

North Tower

- Grand Ballroom BC

Vaccines for Those with Compromised Immune Function Due to Aging and Comorbidities

(co-developed learning activity)

MODERATOR:
Peter Pieroni (MB)

SPEAKER:
Mark Loeb (ON)

At the end of this session, participants should be able to:

  • Explain how aging and comorbidities affect immune function and increase susceptibility to severe infections
  • Describe current technologies used to optimize vaccine efficacy amongst older adults and those with comorbidities
  • Discuss the role of vaccines in reducing risk of severe infections in older adults and those with comorbidities

This educational event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and approved by AMMI Canada. The program was co-developed with AMMI Canada and GSK and was planned to achieve scientific integrity, objectivity, and balance.
Under the guidance of the Innovative Medicines Canada Code of Ethical Practices this event is for healthcare professionals only.

}

15:00 – 15:10

North Tower

- Grand Ballroom Foyer

Break

}

15:10 – 16:10

North Tower

- Grand Ballroom A

Masterclass E

Travel Bug? We've Got a Vaccine for That!

(pre-registration required to maximum of 150 participants)

MODERATOR:
Farhan Khan (NB)

SPEAKERS:
Isaac Bogoch (ON)
Michael Libman (QC)

At the end of this session, participants should be able to:

  • Describe new and emerging vaccines for tropical infectious diseases
  • Describe recommended pre-travel vaccines routinely suggested for Canadians
  • Summarize relevant updates in travel and tropical medicine for Canadian Infectious Diseases providers
}

15:10 – 16:10

North Tower

- Grand Ballroom D

Masterclass B

Congenital Infections with a Focus on CMV and HSV

(pre-registration required to maximum of 150 participants)

MODERATOR:
Earl Rubin (QC)

SPEAKER:
David Kimberlin (AL, USA)

At the end of this session, participants should be able to:

  • Summarize the epidemiology of common congenital infections
  • Discuss presentations and management of common congenital infections
  • Describe preventative measures to reduce the incidence of congenital infections
}

16:10 – 16:15

North Tower

- Grand Ballroom Foyer

Break

}

16:15 – 17:30

North Tower

- Grand Ballroom BC

Your Title Goes Here

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Case Reports Presentations and Closing Remarks

Moderators:
Susan Poutanen (ON)
Rob Kozak (ON)

 

CR001 (#13) Powassan virus encephalitis after tick bite in rural Manitoba
Presenting: Nathan Smith
CR002 (#14) Neck mass misdiagnosed as a possible malignancy: Tularemia, the ancient disease which remains unknown to the medical community and a high risk to laboratory personnel
Presenting: Élodie Gemme
CR003 (#317) Topical, oral, and bladder-instilled phage therapy treats E. coli cystitis: an open-label single patient Canadian clinical trial
Presenting: Greg German
CR004 (#330) Balamuthia mandrillaris : A locally acquired fatal case, possibly a first for Canada?
Presenting: Clayton MacDonald
CR005 (#332) Mediastinal necrotizing lymphadenitis Histoplasmosis in a 16 year old Crohn’s patient
Presenting: Adiel Marom
Closing Remarks Agatha Jassem (BC)
Deb Yamamura (ON)